Home » Newsletters » BioWorld Science

BioWorld Science

April 11, 2016

View Archived Issues

Two-antibody cocktail MIL77E protects primates from Ebola virus

NEOMED Institute announces partnership opportunities

EM Imaging and Mauna Kea enter clinical molecular imaging research collaboration

Researchers present novel murine models to study Zika virus

FDA grants orphan drug designation to ANAVEX 3-71 for frontotemporal dementia

Conference round-up: Biomarker studies from the USCAP Annual Meeting

MRC Technology and IPS-CAS enter antibody research agreement

FDA grants priority review to atezolizumab BLA in NSCLC

Bayer Schering Pharma discloses factor XIa kallikrein B inhibitors

Merck & Co. patents prolyl hydroxylase inhibitors

Shifa Biomedical reports endothelial lipase inhibitors

MedImmune reports antibodies linked to dimeric pyrrolobenzodiazepine

Helmsley Charitable Trust funds research into cell-based therapies for type 1 diabetes

Human Vaccines Project announces Mesa Consortium

Pritumumab receives FDA orphan drug designation for the treatment of pancreatic cancer

Somatostatin-dopamine chimeric compound demonstrates preclinical efficacy for acromegaly

Merck KGaA announces CE Mark approval for OncoBEAM RAS CRC test

FDA advisory committee set to review rociletinib NDA

MSD K.K. and Taiho sign copromotion agreement for pembrolizumab in Japan

Kyoto University and Sumitomo Dainippon Pharma launch second stage of DSK Project

4D pharma acquires Spanish company Instituto Biomar

FDA approves BromSite to prevent pain and treat inflammation following cataract surgery

EMA committee recommends that Alprolix maintains orphan drug designation

Addex Therapeutics announces results from dipraglurant clinical trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...